“paul-aisen” Archives

in
Entry Author Date Location
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug 12/06/19 San Diego
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug 12/05/19 San Diego
Failed Alzheimer’s Drug To Get Another Shot, If Investors Pony Up 03/11/16 Boston
As Feud Rages, UCSD Names New Director to Lead Alzheimer’s Study 01/14/16 San Diego
Our Plan for Reinventing Alzheimer’s Disease R&D at UC San Diego 08/28/15 San Diego
West Coast Biotech Roundup: Adaptive, Synthorx, USC v. UCSD, 23andMe 08/20/15 San Diego
USC Makes Federal Case Out of Dispute Over Alzheimer’s Study 08/19/15 San Diego
USC Countersues UCSD as Fight Over Alzheimer’s Study Intensifies 08/03/15 San Diego
West Coast Biotech Roundup: Hutch, Gilead, Soon-Shiong IPO & More 07/30/15 San Francisco
La Jolla Immunology Institute Agrees to Formal Ties with UCSD 07/29/15 San Diego
Judge Rejects Court Order Requested in Fight Over Alzheimer’s Study 07/16/15 San Diego
New Allegations Fly in Universities’ Fight Over Alzheimer’s Study 07/14/15 San Diego
Analysis: NIH Guidelines Appear to Support UCSD in Alzheimer’s Study 07/13/15 San Diego
West Coast Bio Roundup: Cowboys, UCSD v. USC, Global Blood & More 07/10/15 San Diego
UCSD Asks Court to Restore Custody and Control of Alzheimer’s Data 07/07/15 San Diego
West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More 07/06/15 Seattle
Deeper Issues Underlie UC San Diego Lawsuit Over Raid by USC 07/06/15 San Diego
Page 1 of 1